SYBX - Synlogic Inc logo

Synlogic Inc

SYBX

Synlogic, Inc. develops synthetic biotic medicines targeting rare genetic diseases like Urea Cycle Disorder and Phenylketonuria, utilizing a proprietary synthetic biology platform to advance its clinical-stage drug pipeline.

โš•๏ธ Healthcare NASDAQ Listed 2015 $ USD
$1,000 invested 10 years ago โ†’$97today

Score Overview

1 Year
Scoreโ€”
Net Growth34.83%
Net TrendGrew
Net Income Consistencyโ€”
Rev Growthโ€”
Rev TrendShrank
Revenue Consistencyโ€”
5 Years
Score5.6
Net Growth98.87%
Net Trend80%
Net Income Consistencyโ€”
Rev Growth-100.00%
Rev Trend33%
Revenue Consistencyโ€”
10 Years
Score
Net Growth97.51%
Net Trend40%
Net Income Consistency
Rev Growth-100.00%
Rev Trend50%
Revenue Consistency
All Time
Scoreโ€”
Net Growth97.38%
Net Trend36%
Net Income Consistency
Rev Growthโ€”
Rev Trend56%
Revenue Consistency

Explore the 2021 public Archive ranking โ†’

Where Synlogic Inc has ranked, year by year

Measure
Fundamentals Window

Not enough ranking history to display a chart

This chart needs at least two years of available HDB Score rankings on 10 years of fundamentals. SYBX does not have enough ranked years in the public Archive through 2021.

More recent Archive years are available with Membership. Coverage varies by company and measure.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-10-23
$ 1.05โ€”
1 Year2025-10-23
$ 1.72-38.95%
5 Years2021-10-22
$ 2.67-60.67%
10 Years2016-10-21
$ 10.85-90.32%
All Time2015-10-01
$ 49.35-97.87%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in USD

Year
TTM$ 0.00-$ 655K$ 13M
2025$ 0.00-$ 1M$ 14M
2024-$ 23M$ 18M
2023$ 3M-$ 57M$ 47M
2022$ 1M-$ 66M$ 77M
2021$ 1M-$ 58M$ 128M
2020$ 545K-$ 56M$ 100M
2019$ 2M-$ 48M$ 119M
2018$ 2M-$ 48M$ 122M
2017$ 2M-$ 40M$ 87M
2016$ 444K-$ 26M$ 60M
IPO2015$ 0.00-$ 24M$ 89M
SYBX - Synlogic Inc logo

Synlogic Inc fundamental performance

Between 2020 and 2025, revenue declined from $ 545K to $ 0.00 and net income went from -$ 56M to -$ 1M. Revenue increased in 2 of those 5 years; net income in 4.

Between 2015 and 2025, revenue held from $ 0.00 to $ 0.00 and net income went from -$ 24M to -$ 1M. Revenue increased in 5 of those 10 years; net income in 4.

Synlogic Inc currently holds a 5-year HDB Score of 5.6 out of 10. How the HDB Score is calculated.

Membership

Explore SYBX with current data

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 5,112 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year ยท Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies